Key result
The AdipoR2 SNP cluster (+795G/A, +870C/A, and +963C/T) was associated with significantly higher plasma adiponectin levels and decreased fasting triglyceride levels in patients with metabolic syndrome.
Why the study?
Are genetic variants of adiponectin receptor 2 associated with improved lipid and inflammatory profiles in patients with metabolic syndrome?
Observational (n=20)
Are genetic variants of adiponectin receptor 2 associated with improved lipid and inflammatory profiles in patients with metabolic syndrome?
Genetic variants in the AdipoR2 gene are associated with increased adiponectin and decreased triglyceride/VLDL levels, suggesting a role in lipid metabolism.
Answers are grounded in this paper and cite their sources.
AdipoR2 variants may link to better lipids in metabolic syndrome; leaves open causal effects and clinical utility pending prospective data.
BACKGROUND: Adiponectin acts as an antidiabetic, antiinflammatory and antiatherogenic adipokine. These effects are assumed to be mediated by the recently discovered adiponectin receptors AdipoR1 and AdipoR2. AIM: The purpose of this study was to determine whether variations in the AdipoR1 and AdipoR2 genes may contribute to insulin resistance, dyslipidemia and inflammation. METHODS: We sequenced all seven coding exons of both genes in 20 unrelated German subjects with metabolic syndrome and tested genetic variants for association with glucose, lipid and inflammatory parameters. RESULTS: We identified three AdipoR2 variants (+795G/A, +870C/A and +963C/T) in perfect linkage disequilibrium (r2 = 1) with a minor allele frequency of 0.125. This haplotype was associated with higher plasma adiponectin levels and decreased fasting triglyceride, VLDL-triglyceride and VLDL-cholesterol levels. No association, however, was observed between the AdipoR2 SNP cluster and glucose metabolism. CONCLUSION: To our knowledge, this is the first study to identify an association between genetic variants of the adiponectin receptor genes and plasma adiponectin levels. Furthermore, our data suggest that AdipoR2 may play an important role in triglyceride/VLDL metabolism.
No takes yet. Share an insight, caveat, or question.
Broedl et al. (2006) conducted an observational in Metabolic syndrome (insulin resistance and abdominal overweight) (n=20). AdipoR2 SNP cluster (+795G/A, +870C/A, +963C/T) vs. Absence of AdipoR2 SNP cluster was evaluated on Fasting triglycerides (mg/dl) at baseline (p=0.01). The AdipoR2 SNP cluster (+795G/A, +870C/A, and +963C/T) was associated with significantly higher plasma adiponectin levels and decreased fasting triglyceride levels in patients with metabolic syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: